The Science of Certainty: How PGT-A Testing Transforms IVF Success
One of the most heartbreaking experiences in an IVF journey is a failed embryo transfer or an early miscarriage. Often, these tragedies occur due to invisible chromosomal abnormalities within the embryo itself. Enter PGT-A (Preimplantation Genetic Testing for Aneuploidies)—a revolutionary technology available at Superior A.R.T BD that takes the guesswork out of embryo selection.
What is PGT-A?
PGT-A is an advanced screening test performed on embryos created via IVF before they are transferred to the uterus. A highly skilled embryologist safely removes a few microscopic cells from the outer layer of a 5-day-old embryo (blastocyst). These cells are tested to ensure the embryo has the correct number of chromosomes (46).
Why is PGT-A a Game Changer?
At Superior A.R.T BD, integrating PGT-A into our cycles has allowed us to achieve a staggering 75% pregnancy success rate for PGT-A cycles. The benefits include:
Higher Implantation Rates:
Transferring an embryo confirmed to be chromosomally normal (euploid) dramatically increases the chance of implantation.
Reduced Miscarriage Risk:
Most early miscarriages are caused by chromosomal errors. PGT-A minimizes this risk, protecting your emotional and physical well-bein
Fewer IVF Cycles Needed:
By only transferring the healthiest embryos, patients reach a successful pregnancy faster, saving time and overall costs.
Who Should Consider PGT-A?
While highly beneficial for many, PGT-A is particularly recommended for women over the age of 35, couples with a history of recurrent miscarriages, or those who have experienced multiple failed IVF cycles.
5 FAQs:
When performed by our expert embryologists at Superior A.R.T BD, the risk to the embryo is extremely low (less than 1%).
Results typically take 1 to 2 weeks. The embryos are safely frozen while waiting for the results.
While it dramatically increases the odds (up to 75%), it is not a 100% guarantee, as uterine receptivity also plays a role.
PGT-A screens for chromosomal health, but the test inherently reveals the sex chromosomes. (Note: Please review our specific guidelines regarding gender selection regulations).
For many patients, yes. By reducing failed transfers and miscarriages, it often saves money and emotional heartache in the long run.
